will crypto- Top People also ask

 China Tiewu, etc. established the General Lugang International Logistics Company in Gansu. According to the enterprise search APP, recently, China Railway General Lugang International Logistics (Gansu) Co., Ltd. was established, with Ouyang Bing as the legal representative and a registered capital of 30 million yuan. Its business scope includes: domestic cargo transportation agents; International freight forwarder; Road freight transportation (excluding dangerous goods), etc. Enterprise equity penetration shows that the company is jointly held by China Railway General Supply Chain Technology Group Co., Ltd., a wholly-owned subsidiary of China Tiewu, and Lanzhou New District Lugang Logistics Co., Ltd.Pakistan KSE-100 index rose 0.5% to 109,693.20.

IDC: It is estimated that the edge cloud market in China will grow at a compound annual rate of over 25% from 2023 to 2028. Recently, the latest report "China Edge Cloud Market Tracking Research, 2024H1" released by International Data Corporation (IDC) shows that in the first half of the year, the edge cloud market in China totaled 5.48 billion yuan, with a year-on-year growth rate of 21.0%. Among them, the market scale of edge public cloud services, edge exclusive cloud services and edge cloud solutions reached 3 billion yuan, 970 million yuan and 1.5 billion yuan respectively. According to IDC, it is estimated that the average annual compound growth rate of China's edge cloud market will be 25.5% from 2023 to 2028, taking into account the changing trend of customer expenditure in major industries, the commercialization progress of hot demand and the changes of bandwidth supply policy throughout the year.Spot gold fell in the short term, just breaking through the $2,690.00/oz mark, and the latest report was $2,689.72/oz, down 0.15% in the day.Li Jiaqi said it was a rumor to go to the entertainment industry and he was optimistic about the future of the live broadcast industry. Li Jiaqi said in an interview that I have always been an optimist. I don't think the live broadcast e-commerce industry can be as it is now, and technological innovation will definitely bring changes and opportunities. Li Jiaqi also talked about the experience of participating in variety shows. He said that it is a rumor to go to the entertainment industry. "A person has more than one identity in his life. I can be an anchor, a singer or an actor." (The Paper)

Five members of South Korea's ruling party supported the impeachment of Yin Xiyue. Kim Jae-sub, a member of South Korea's ruling National Power Party, announced through live television that he would no longer abide by the ruling party's position of opposing the impeachment of President Yin Xiyue and would vote in favor of the next presidential impeachment case. At present, five members of South Korea's ruling party have indicated that they will support the impeachment of President Yin Xiyue. There are 300 seats in South Korea's National Assembly, and the impeachment case of the President must obtain at least 2/3, that is, at least 200 members vote in favor before it can pass the National Assembly and enter the trial stage of the Korean Constitutional Court. At present, South Korea's parliament, including the largest opposition party, the Common Democratic Party, has 192 seats in the opposition camp and 108 seats in the ruling party. On the premise that all members of the opposition camp voted for impeachment, only eight members of the ruling party voted for it, and Yin Xiyue's impeachment case will pass the parliament. At present, three members of parliament from the ruling party need to vote for impeachment. (CCTV International News)Pakistan KSE-100 index rose 0.5% to 109,693.20.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.